Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer

A pharmacokinetic analysis program (multi) for microcomputer.

Kiyoshi Yamaoka, Yusuke Tanigawara, Terumichi Nakagawa et al. · Journal of Pharmacobio-Dynamics · 1981 · 2.5K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion

Sewa S. Legha, Robert S. Benjamin, Bruce R. MacKay et al. · Annals of Internal Medicine · 1982 · 769 citations

Medicine, Pharmacology, Cardio-oncology +13

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

MH Bronchud, J.H. Scarffe, Nicholas Thatcher et al. · British Journal of Cancer · 1987 · 597 citations · Full text

Medicine, Hematology, Oncology +15

Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

Robert S. Benjamin, Peter H. Wiernik, Nicholas R. Bachur · Cancer · 1974 · 392 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

Gabriel N. Hortobágyi, D. Frye, Aman U. Buzdar et al. · Cancer · 1989 · 200 citations · Full text

Medicine, Oncology, Pharmacology +17